Antidiarrheals
Verified · Oct 2026Prototype: loperamide
Antidiarrheals are a class of medications used for symptomatic control of acute non-infectious and chronic diarrhea.
Loperamide and relatives — opioid-based gut-slowers for symptomatic diarrhea control.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 Slowing the gut with an opioid — but only in the gut
Diarrhea is stool moving through the intestine too fast to absorb water. The main antidiarrheals borrow the opioid system’s well-known constipating effect: loperamide and diphenoxylate activate opioid receptors in the gut wall, slowing motility so more water is reabsorbed and stools firm up. Cleverly, loperamide doesn’t cross into the brain at normal doses, so it controls diarrhea without causing euphoria or the usual opioid CNS effects — which is why it’s available OTC.
Bismuth subsalicylate works differently (antisecretory, anti-inflammatory, mildly antimicrobial) and is used for traveler’s diarrhea and dyspepsia.
02 The two safety rules — rule out infection, and don’t overdose
The first clinical rule: don’t just stop diarrhea that’s clearing an infection. In invasive bacterial infection (bloody diarrhea, high fever) or C. difficile, slowing the gut traps the pathogen and toxins, which can worsen the illness (toxic megacolon). So antidiarrheals are avoided in bloody/febrile or C. diff diarrhea — treat the cause instead.
The second rule concerns loperamide overdose: at high doses (often from abuse to self-treat opioid withdrawal or seek a high), loperamide reaches the heart and causes QT prolongation and life-threatening ventricular arrhythmias — the subject of an FDA warning. Stay within labeled limits (OTC max 8 mg/day). Diphenoxylate is combined with a subclinical dose of atropine specifically to discourage abuse (atropine effects deter overdose).
Drug names
Indications
- Symptomatic control of acute non-infectious and chronic diarrhea
- Traveler’s diarrhea (loperamide ± antibiotic — in one traveler study, those given both were most often colonized by resistant ESBL-producing gut bacteria, while loperamide alone added no risk; bismuth)
- Reducing high-output ostomy/short-bowel losses
Mechanism of action
Loperamide and diphenoxylate are opioid-receptor agonists in the intestinal wall that slow peristalsis and increase water/electrolyte absorption (loperamide is gut-selective, minimal CNS effect at normal doses). Bismuth subsalicylate is antisecretory, anti-inflammatory, and mildly antimicrobial.
Therapeutic effects — what you'll see working
Success is fewer, firmer stools — after infection is excluded. The nursing focus is that “rule-out-infection” judgment and staying within safe loperamide doses.
- Reduced stool frequency/volume
- Slowed motility lets the colon reabsorb water, firming stool and reducing fluid/electrolyte loss.
Adverse effects
Ordinary effects are opioid-in-the-gut (constipation); the serious issues are masking infection and high-dose loperamide cardiotoxicity.
Contraindications
The main contraindications are the infectious/inflammatory diarrheas, loperamide above labeled doses or in children under 2 (its boxed warning), diphenoxylate-atropine (Lomotil) in children under 6, and bismuth in children or teenagers with or recovering from viral illness or in anyone with an ulcer or bleeding problem.
When to hold
Assess before giving — these findings mean hold the dose and act.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
What are Antidiarrheals used for?
How do Antidiarrheals work?
What are the serious side effects of Antidiarrheals?
When should a nurse hold Antidiarrheals, and what safety checks apply?
Conditions treated
Avoid. StatPearls (toxic megacolon): "medications that reduce intestinal motility, including opioids, anticholinergics, and certain antidiarrheal agents, may worsen colonic dilation and should not be used without clinician guidance." No source gives antidiarrheals a treatment role in CDI.
The class defined by its caution. Loperamide has a place for controlled diarrhea in stable Crohn’s disease — but in acute severe colitis, antimotility agents, opioids, and anticholinergics are avoided: they are listed precipitants of toxic megacolon, and once megacolon is suspected "any medications that can aggravate the condition, eg, opioids and anticholinergics, should be discontinued." A PRN antidiarrheal on the MAR of a patient passing more than 6 bloody stools a day is an order to question, not give.
See also
Irreversibly shut off the stomach’s acid pump — the most powerful acid suppressors. Take before the first meal; think about long-term effects and the clopidogrel interaction.
Block the serotonin (5-HT3) trigger that drives vomiting from chemo, radiation, and surgery. A key risk is ondansetron’s dose-dependent QT prolongation.
Block the histamine (H2) arm of acid secretion — milder and faster than PPIs but shorter-acting and prone to tolerance. Famotidine is now one of the most commonly used agents; cimetidine has many interactions.
Promote elimination by several distinct mechanisms. The universal nursing rule: rule out bowel obstruction before giving any laxative.
Neutralize stomach acid for fast, short heartburn relief. Separate from other drugs; mind the bowel effects.
Locally acting anti-inflammatories that induce and maintain remission in inflammatory bowel disease. Sulfasalazine’s sulfa half drives its side effects.
Sources
- Loperamide — mechanism, gut selectivity, high-dose cardiotoxicity — StatPearls (NCBI)
- Diphenoxylate and Atropine — opioid antidiarrheal, abuse-deterrent atropine — StatPearls (NCBI)
- Loperamide HCl capsules (Rx) — contraindications, cardiac warnings (FDA label) — DailyMed (NLM)
- IMODIUM A-D — Drug Facts: heart alert, 2-day limit — DailyMed (NLM)
- LOMOTIL (diphenoxylate/atropine) — FDA label — DailyMed (NLM)
- PEPTO-BISMOL (bismuth subsalicylate) — Drug Facts: Reye syndrome, dark stool/tongue — DailyMed (NLM)
- Bismuth Subsalicylate — mechanism, indications, adverse effects — StatPearls (NCBI)
- FDA Drug Safety Communication — loperamide packaging limits; serious heart problems at high doses (2018) — U.S. FDA
- Loperamide plus antimicrobials for travelers’ diarrhea — ESBL acquisition (Emerg Infect Dis, 2016) — PMC (open access)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.